Northern Trust’s Charles River Laboratories CRL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $74.5M | Sell |
|
|||||
|
2025
Q2 | $72.4M | Sell |
|
|||||
|
2025
Q1 | $74.1M | Buy |
|
|||||
|
2024
Q4 | $90.9M | Buy |
|
|||||
|
2024
Q3 | $85.4M | Sell |
|
|||||
|
2024
Q2 | $94.6M | Sell |
|
|||||
|
2024
Q1 | $124M | Sell |
|
|||||
|
2023
Q4 | $114M | Sell |
|
|||||
|
2023
Q3 | $97.5M | Buy |
|
|||||
|
2023
Q2 | $99.5M | Sell |
|
|||||
|
2023
Q1 | $99.1M | Sell |
|
|||||
|
2022
Q4 | $108M | Buy |
|
|||||
|
2022
Q3 | $97.3M | Sell |
|
|||||
|
2022
Q2 | $107M | Sell |
|
|||||
|
2022
Q1 | $144M | Sell |
|
|||||
|
2021
Q4 | $195M | Sell |
|
|||||
|
2021
Q3 | $218M | Buy |
|
|||||
|
2021
Q2 | $190M | Buy |
|
|||||
|
2021
Q1 | $127M | Buy |
|
|||||
|
2020
Q4 | $99.1M | Sell |
|
|||||
|
2020
Q3 | $92M | Sell |
|
|||||
|
2020
Q2 | $73.9M | Buy |
|
|||||
|
2020
Q1 | $52M | Buy |
|
|||||
|
2019
Q4 | $60.1M | Buy |
|
|||||
|
2019
Q3 | $51M | Sell |
|
|||||
|
2019
Q2 | $54.9M | Buy |
|
|||||
|
2019
Q1 | $55.7M | Buy |
|
|||||
|
2018
Q4 | $42.2M | Buy |
|
|||||
|
2018
Q3 | $49.7M | Sell |
|
|||||
|
2018
Q2 | $42.7M | Sell |
|
|||||
|
2018
Q1 | $44M | Sell |
|
|||||
|
2017
Q4 | $46.4M | Sell |
|
|||||
|
2017
Q3 | $46M | Sell |
|
|||||
|
2017
Q2 | $44.2M | Buy |
|
|||||
|
2017
Q1 | $38.7M | Buy |
|
|||||
|
2016
Q4 | $32M | Buy |
|
|||||
|
2016
Q3 | $35M | Buy |
|
|||||
|
2016
Q2 | $33.9M | Buy |
|
|||||
|
2016
Q1 | $30.7M | Buy |
|
|||||
|
2015
Q4 | $31.6M | Sell |
|
|||||
|
2015
Q3 | $25.2M | Buy |
|
|||||
|
2015
Q2 | $27.5M | Sell |
|
|||||
|
2015
Q1 | $31.7M | Sell |
|
|||||
|
2014
Q4 | $25.7M | Buy |
|
|||||
|
2014
Q3 | $22.9M | Sell |
|
|||||
|
2014
Q2 | $21.7M | Buy |
|
|||||
|
2014
Q1 | $23.9M | Buy |
|
|||||
|
2013
Q4 | $20.9M | Sell |
|
|||||
|
2013
Q3 | $18.4M | Sell |
|
|||||
|
2013
Q2 | $16.8M | Buy |
|